Skip to main content
. 2020 Nov 30;64(1):80–89. doi: 10.5468/ogs.20186

Fig. 5.

Fig. 5

The overall survival (OS) rate analyzed by the treatment and recurrence risk; (A) low-risk group, (B) intermediate-risk group, (C) high-risk group. LN, lymph node; AC, adjuvant chemotherapy; ns, not significant.